The Outcomes of Using Colistin for Treating Multidrug Resistant Acinetobacter Species Bloodstream Infections

Despite the identification of Acinetobacter baumannii isolates that demonstrate susceptibility to only colistin, this antimicrobial agent was not available in Korea until 2006. The present study examined the outcomes of patients with multidrug resistant (MDR) Acinetobacter species bloodstream infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Seung-Kwan, Lee, Sang-Oh, Choi, Seong-Ho, Choi, Jae-Phil, Kim, Sung-Han, Jeong, Jin-Yong, Choi, Sang-Ho, Woo, Jun Hee, Kim, Yang Soo
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051077/
https://www.ncbi.nlm.nih.gov/pubmed/21394298
http://dx.doi.org/10.3346/jkms.2011.26.3.325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051077/
https://www.ncbi.nlm.nih.gov/pubmed/21394298
http://dx.doi.org/10.3346/jkms.2011.26.3.325

Ejemplares similares